MSH2 genomic deletions are a frequent cause of HNPCC (original) (raw)
- Correspondence
- Published: 01 December 1998
- Heleen van der Klift1,
- Hans Vasen2,
- P. Meera Khan1,
- Fred Menko3,
- Carli Tops4,
- Hanne Meijers Heijboer5,
- Dick Lindhout5,
- Pål Møller6 &
- …
- Ricardo Fodde.1
Nature Genetics volume 20, pages 326–328 (1998)Cite this article
- 818 Accesses
- 187 Citations
- Metrics details
Hereditary non-polyposis colorectal cancer (HNPCC) is a common, autosomal dominant, cancer susceptibility condition characterized by early onset colorectal cancer1. HNPCC is caused by germline mutations in one of five DNA mismatch repair genes (MMR): MSH2 (ref. 2), MLH1 (Refs 3,4), PMS1 (ref. 5), PMS2 ( ref. 5) and MSH6 (Refs 6,7). To date, more than 200 different predisposing mutations in these genes have been characterized in HNPCC patients, the majority of which occur in MSH2 and MLH1 (ref. 8; see also http://www.nfdht.nl/index.htm). Here, we report that genomic deletions at MSH2 also represent a frequent cause of HNPCC. In fact, these deletions comprise more than one-third of all pathogenic MSH2 mutations among Dutch HNPCC families and account for 6.5% of HNPCC defined by the Amsterdam criteria.
Little is known about the number or location of _Alu_-repeats in MSH2, however, MSH2 deletions encompassing exon 1, exons 1-6 and exons 4-8 have been detected13,14,15. The presence of recurring deletions in several HNPCC families could be indicative of a founder mutation or of the independent occurrence of the same rearrangement due to the presence of recombinogenic sequences such as Alu repeats. Haplotype analysis of the kindreds sharing the same deletions failed to show evidence of a founder effect (data not shown). These observations indicate that the deletions reported here arose independently through a common recombination event.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
References
- Lynch, H.T. et al. Gastroenterology 104, 1535–1549 (1993).
Article CAS Google Scholar - Leach, F.S. et al. Cell 75, 1215–1225 (1993).
Article CAS Google Scholar - Papadopoulos, N. et al. Science 263, 1625– 1629 (1994).
Article CAS Google Scholar - Bronner, C.E. et al. Nature 368, 258–261 (1994).
Article CAS Google Scholar - Nicolaides, N.C. et al. Nature 371, 75–80 (1994).
Article CAS Google Scholar - Akiyama, Y. et al. Cancer Res. 57, 3920– 3923 (1997).
CAS PubMed Google Scholar - Miyaki, M. et al. Nature Genet. 17, 271– 272 (1997).
Article CAS Google Scholar - Peltomäki, P. et al. Gastroenterology 113, 1146– 1158 (1997).
Article Google Scholar - Wijnen, J.T. et al. Am. J. Hum. Genet. 61, 329– 335 (1997).
Article CAS Google Scholar - Wijnen, J.T. et al. N. Engl. J. Med. 339, 511– 518 (1998).
Article CAS Google Scholar - Nyström-Lahti, M. et al. Nature Med. 1, 1203– 1206 (1995).
Article Google Scholar - Mauillon, J.L. et al. Cancer Res. 56, 5728– 5733 (1996).
CAS PubMed Google Scholar - Boyer, J.C. et al. Cancer Res. 55, 6063– 6070 (1995).
CAS PubMed Google Scholar - Liu, B. et al. Nature Genet. 9, 48–55 (1995).
Article CAS Google Scholar - Papadopoulos, N. et al. Nature Genet. 11, 99– 101 (1995).
Article CAS Google Scholar - Petrij-Bosch, A. et al. Nature Genet. 17, 341– 345 (1997).
Article CAS Google Scholar
Acknowledgements
The authors are grateful to M. de Almeida for technical assistance and the following clinicians for contributing their HNPCC families: F. Nagengast, A. Bröcker-Vriends, G. Griffioen, A. Cats and J. Kleibeuker. This work has been supported in part by the Dutch Cancer Society and Praeventiefonds (project no. PRF 28-1383-1).
Author information
Authors and Affiliations
- MGC-Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
Juul Wijnen, Heleen van der Klift, P. Meera Khan & Ricardo Fodde. - The Foundation for the Detection of Hereditary Tumors, and Department of Gastroenterology, Leiden University Medical Center, Leiden, The Netherlands
Hans Vasen - Department of Clinical Genetics, Free University Hospital, Amsterdam, The Netherlands
Fred Menko - Clinical Genetic Center Leiden, Leiden University Medical Center, Leiden, The Netherlands
Carli Tops - MGC-Department of Clinical Genetics, Erasmus University Rotterdam, Rotterdam, The Netherlands
Hanne Meijers Heijboer & Dick Lindhout - The Norwegian Radium Hospital, Oslo, Norway
Pål Møller
Authors
- Juul Wijnen
You can also search for this author inPubMed Google Scholar - Heleen van der Klift
You can also search for this author inPubMed Google Scholar - Hans Vasen
You can also search for this author inPubMed Google Scholar - P. Meera Khan
You can also search for this author inPubMed Google Scholar - Fred Menko
You can also search for this author inPubMed Google Scholar - Carli Tops
You can also search for this author inPubMed Google Scholar - Hanne Meijers Heijboer
You can also search for this author inPubMed Google Scholar - Dick Lindhout
You can also search for this author inPubMed Google Scholar - Pål Møller
You can also search for this author inPubMed Google Scholar - Ricardo Fodde.
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toRicardo Fodde..
Rights and permissions
About this article
Cite this article
Wijnen, J., van der Klift, H., Vasen, H. et al. MSH2 genomic deletions are a frequent cause of HNPCC.Nat Genet 20, 326–328 (1998). https://doi.org/10.1038/3795
- Issue Date: 01 December 1998
- DOI: https://doi.org/10.1038/3795